Luteolin induces mitochondria-dependent apoptosis in human lung adenocarcinoma cell

Natural Product Communications

Volumn 7, Issue 1, 2012, Pages 29-32

  Chen, Qing ^a   Liu, Shengming ^a   Chen, Jinghong ^b   Zhang, Qianqian ^a   Lin, Shijie ^a   Chen, Zhiming ^b   Jiang, Jianwei ^b  

^a JINAN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

A549; Apoptosis; Luteolin; Mitochondria

Indexed keywords

CASPASE 3; CASPASE 9; LUTEOLIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL NUCLEUS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MEMBRANE POTENTIAL; MITOCHONDRION; PLOIDY; PROTEIN EXPRESSION; WESTERN BLOTTING; ADENOCARCINOMA; CELL CYCLE; DRUG EFFECT; LUNG TUMOR; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; LUTEOLIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84860665044     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1200700111     Document Type: Article

References (18)

1. (a) Spiro SG, Porter JC. (2002) Lung cancer - Where are we today? Current advances in staging and nonsurgical treatment, American Journal of Respiratory and Critical Care Medicine, 166, 1166-1196;
2. (b) Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. (2008) Cancer statistics, 2008. A Cancer Journal for Clinicians, 58, 71-96;
3. (c) Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Jr SB, Olak J Stover D Strawn JR, Turrisi AT, Somerfield MR. (2004) American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. Journal of Clinical Oncology, 22, 330-353;
4. (d) Stinchcombe TE, Socinski MA. (2009) Current treatments for advanced stage non-small cell lung cancer. The Proceedings of the American Thoracic Society, 6, 233-241;
5. (e) Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. The New England Journal of Medicine, 355, 2542-2550;
6. (f) Shepherd FA, Pereira JR, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S, Smylie M, Martins R, Kooten MV, Dediu M, Findlay B, Tu D, Johnston D, Bezjak A, Clark G, Santabárbara P, Seymour L.(2005) Erlotinib in previously treated non-small-cell lung cancer. The New England Journal of Medicine, 353, 123-132. (Pubitemid 41058344)
7. (a) Cory S, Huang DCS, Adams JM. (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene, 22, 8590-8607;
8. (b) Niquet J, Wasterlain CG. (2004) Bim, Bad, and Bax: a deadly combination in epileptic seizures. The Journal of Clinical Investigation, 113, 960-962. (Pubitemid 38544116)
9. (a) Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C. (2002) Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax Ratio.Cancer Research, 62, 4592-4598;
10. (b) Katiyar SK, Roy AM, Baliga MS. (2005) Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl- 2/Bax, cytochrome c release, and caspase activation. Molecular Cancer Therapeutics, 4, 207-216;
11. (c) Giam M, Huang DCS, Bouillet P. (2008) BH3-only proteins and their roles in programmed cell deathBH3-only proteins and their roles. Oncogene, 27, S128-S136;
12. (d) Kim JH, Lee EO, Lee HJ, Ku JS, Lee MH, Yang DC, Kim SH. (2007) Caspase activation and extracellular signal-regulated kinase/akt inhibition were involved in luteolin-induced apoptosis in Lewis lung carcinoma cells. Annals of the New York Academy of Sciences, 1095, 598-611.
13. (a) Wang C, Youle R. (2009) The role of mitochondria in apoptosis. Annual Review of Genetics, 43, 95-118;
14. (b) Doi S, Soda H, Oka M, Tsurutani J, Kitazaki T, Nakamura Y, Fukuda M, Yamada Y, Kamihira S, Kohno S. (2004) The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells, Molecular Cancer Therapeutics, 3, 1397-402;
15. (c) Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, McAlpine D, Johns J, Scott TM, Sutherland KP, Gardner JM, Le TTT, Lenarczyk A, Aylward JH, Parsons PG. (2004) Expand+antitumor activity of 3-ingenyl angelate plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Research, 64, 2833-2839. (Pubitemid 38500622)
16. (a) Chen Z, Jin K, Gao L, Lou G, Jin Y, Yu Y, Lou Y. (2010) Anti-tumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line. European Journal of Pharmacology, 643, 170-179;
17. (b) Lai WW, Yang JS, Lai KC, Kuo CL, Hsu CK, Wang CK, CHang CY, Lin JJ, Tang NJ, Chen PY, Huang WW, Chung JG. (2009) Rhein induced apoptosis through the endoplasmic reticulum stress, caspase-and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells. In Vivo, 23, 309-316;
18. (c) Huang M, Camara AKS, Stowe DF, Beard DA. (2007) Quantitative analysis of mitochondrial membrane potential measurements with JC-1. The FASEB Journal, 21, A1351-A1351.